```html

Jaguar Fever (Bartonella Infection) – A Complete Patient Guide

Overview

Jaguar fever is a colloquial name sometimes used for acute infection with bacteria of the genus Bartonella. The term originated from early case reports describing fever and lymphadenopathy in people handling jaguar carcasses in South America, but today the infection is recognized worldwide and is most commonly linked to cat‑scratch disease (B. henselae) and trench fever (B.  quintana). Bartonella species are Gram‑negative intracellular bacteria that can infect endothelial cells, red blood cells, and macrophages.

Who it affects: Anyone can become infected, but certain groups are at higher risk:

• Children and adolescents (especially those who play with cats)
• People experiencing homelessness or living in crowded conditions (associated with body‑lice transmission of B. quintana)
• Individuals with weakened immune systems (HIV, organ‑transplant recipients, chemotherapy patients)
• Veterinarians, wildlife rehabilitators, and hunters who handle mammals

Prevalence: Bartonella infections are under‑diagnosed, but estimates suggest:

• Cat‑scratch disease: 1–4 cases per 100,000 population in North America and Europe each year [CDC].
• Trench fever (louse‑borne): ~15,000–30,000 cases annually worldwide, predominantly in areas with poor sanitation [WHO].
• Other Bartonella species (e.g., B. bacilliformis causing Carrion’s disease) are endemic in high‑altitude regions of the Andes, affecting 1–2 % of the population in some valleys [CDC].

Symptoms

The clinical picture varies widely depending on the species, the route of transmission, and the host’s immune status. Below is a comprehensive symptom list grouped by the most common disease presentations.

Acute Cat‑Scratch Disease (CSD) – B. henselae

• Fever – usually low‑grade (37.5–38.5 °C) but can spike to 39 °C.
• Papular or pustular skin lesion at the site of a cat bite/scratch, appearing within 3‑10 days.
• Regional lymphadenopathy – tender, enlarging nodes near the inoculation site; may become fluctuant.
• Headache, malaise, and fatigue – nonspecific systemic symptoms.
• Splenomegaly or hepatomegaly – more common in children.

Trench Fever – B. quintana

• Recurrent, relapsing fever spikes (38‑40 °C) lasting 2‑5 days, often every 4‑6 weeks.
• Severe headache and photophobia.
• Muscle aches (myalgia) and joint pain (arthralgia).
• Maculopapular rash on trunk or limbs (≈30 % of cases).
• Occasional abdominal pain and mild hepatosplenomegaly.

Carrión’s Disease (Bartonellosis) – B. bacilliformis

• Acute phase (Oroya fever) – high fever (≥40 °C), severe hemolytic anemia, jaundice, and profound weakness.
• Chronic phase (verruga peruana) – angiomatous skin lesions that bleed easily.

Other Manifestations (often in immunocompromised hosts)

• Endocarditis – fever, new murmur, embolic phenomena.
• Neurobartonellosis – encephalitis, meningitis, or peripheral neuropathy.
• Ocular disease – uveitis, focal retinitis.
• Granulomatous hepatitis or splenic lesions.

Causes and Risk Factors

Bartonella bacteria are zoonotic; they move from animals to people through vectors or direct contact.

Primary Transmission Routes

• Cat scratches or bites – the most common route for B. henselae. Cats become bacteremic after flea bites; the bacteria reside in flea feces and can be inoculated into the skin.
• Body lice (Pediculus humanus corporis) – transmit B. quintana during prolonged close contact, especially in homeless shelters or war‑zone trenches.
• Sandflies (Lutzomyia spp.) – vector for B. bacilliformis in Andean valleys.
• Blood transfusion or organ transplantation – rare but documented cases of Bartonella bacteremia transmitted via these routes.
• Other mammals – dogs, rabbits, rodents, and wildlife (e.g., jaguars, raccoons) can harbor Bartonella; handling their carcasses without protective equipment is a risk.

Risk Factors

• Living with or frequently handling cats, especially kittens.
• Flea infestation in the home or on pets.
• Homelessness, overcrowded housing, or lack of personal hygiene (lice exposure).
• Travel to or residence in endemic high‑altitude regions of South America.
• Immunosuppression (HIV, chemotherapy, chronic corticosteroid use).
• Occupational exposure – veterinarians, wildlife rehabilitators, laboratory personnel.

Diagnosis

Because Bartonella infections mimic many other febrile illnesses, a combination of clinical suspicion and targeted testing is essential.

Clinical Evaluation

• Detailed exposure history (cat contact, travel, lice, etc.).
• Physical exam focused on skin lesions, lymphadenopathy, and organomegaly.

Laboratory Tests

• Serology (IgG/IgM ELISA or indirect fluorescence assay) – detects antibodies against specific Bartonella species; useful after 2‑3 weeks of symptom onset. Sensitivity 70‑85 %, specificity ~95 %.
• Polymerase Chain Reaction (PCR) – identifies bacterial DNA from blood, tissue biopsy, or wound samples. PCR has the highest specificity (>98 %) and can differentiate species.
• Blood cultures – notoriously low yield (<5 %) because Bartonella are fastidious; special enriched media (BAPGM) increase detection.
• Complete blood count (CBC) – may show anemia, leukocytosis, or thrombocytopenia, especially in severe cases.
• Liver function tests – mild transaminitis in systemic disease.
• Echocardiography – indicated if endocarditis is suspected.

Imaging

• Ultrasound or CT of the abdomen for hepatosplenic lesions.
• MRI of the brain when neurobartonellosis is considered.

Diagnostic Criteria (CDC & WHO)

A probable case is defined by compatible clinical syndrome + positive serology or PCR. A confirmed case requires culture or histopathologic evidence of Bartonella organisms.

Treatment Options

Management depends on the species, disease severity, and host immune status.

First‑Line Antibiotics

• Azithromycin – 5 days (500 mg on day 1, then 250 mg daily) is the preferred regimen for uncomplicated cat‑scratch disease (Level A recommendation, CDC).
• Doxycycline – 100 mg orally twice daily for 2‑4 weeks; effective for B. quintana, endocarditis, and systemic infections.
• Rifampin – added in refractory cases or when intracellular penetration is needed (often combined with doxycycline).

Severe or Complicated Cases

• Combination therapy – doxycycline + rifampin for 4‑6 weeks (endocarditis, osteomyelitis).
• Intravenous (IV) options – ceftriaxone or gentamicin for acute severe bacteremia, especially in immunocompromised patients.
• Supportive care – blood transfusions for severe anemia in Oroya fever, analgesics for pain, antipyretics for fever.

Procedural Interventions

• Incision and drainage of suppurative lymph nodes when abscess formation occurs.
• Surgical valve replacement if Bartonella endocarditis leads to heart failure.

Adjunctive Measures

• Flea control for pets (monthly topical or oral products).
• Improved hygiene and lice eradication programs in at‑risk communities.
• Monitoring liver enzymes during prolonged doxycycline or rifampin therapy.

Living with Jaguar Fever (Bartonella Infection)

Even after successful treatment, some individuals experience lingering fatigue or recurrent lymphadenopathy. Below are practical tips for daily management.

• Follow‑up testing – repeat serology or PCR 4‑6 weeks after therapy to confirm eradication, especially for endocarditis or immunocompromised patients.
• Maintain a symptom diary – record fever spikes, pain, or new skin lesions to discuss with your clinician.
• Nutrition and rest – a balanced diet rich in iron and vitamin C supports immune recovery; aim for 7‑9 hours of sleep per night.
• Physical activity – gentle aerobic exercise (e.g., walking) once fever resolves can improve stamina.
• Pet care – keep cats indoors, use flea‑preventive products, and wash hands after handling animals or cleaning litter boxes.
• Medication adherence – complete the full course of antibiotics even if symptoms improve; missed doses can lead to relapse.
• Vaccination – while no vaccine exists for Bartonella, staying up‑to‑date with influenza, pneumococcal, and COVID‑19 vaccines reduces the burden of secondary infections.

Prevention

Because Bartonella is transmitted from animals or vectors, preventive strategies focus on minimizing exposure.

• Flea control – treat all household pets with veterinarian‑recommended flea products; clean bedding and vacuum regularly.
• Safe handling of cats – wear gloves when cleaning litter boxes, avoid rough play that could lead to scratches, and promptly clean any wounds with soap and water.
• Lice eradication – regular bathing, clean clothing, and prompt treatment of infestations using permethrin or ivermectin as directed.
• Protective gear for at‑risk workers – gloves, masks, and eye protection when handling wildlife or performing necropsies.
• Travel precautions – use insect repellent (DEET ≥30 %) and wear long sleeves when visiting high‑altitude Andean regions.
• Screening of blood donors – some blood banks now test for Bartonella DNA in high‑risk donors to prevent transfusion‑transmitted infection.

Complications

When left untreated or inadequately treated, Bartonella infections can progress to serious sequelae.

• Chronic lymphadenopathy – may persist for months, occasionally requiring surgical excision.
• Endocarditis – high‑mortality condition; often culture‑negative and requires prolonged combination antibiotics plus possible valve surgery.
• Neurobartonellosis – encephalitis, seizures, or peripheral neuropathy that may lead to lasting neurological deficits.
• Ocular involvement – uveitis can cause permanent vision loss if not treated promptly.
• Severe anemia – especially in Oroya fever; can be fatal without transfusion.
• Pregnancy complications – rare reports of intrauterine infection leading to fetal loss.

When to Seek Emergency Care

References

1. Centers for Disease Control and Prevention. Bartonella (Cat‑Scratch Disease) – CDC. Accessed May 2026.
2. World Health Organization. Trench Fever Fact Sheet. Accessed May 2026.
3. Mayo Clinic. Cat‑Scratch Disease. Updated 2024.
4. Cleveland Clinic. Bartonella Infection. Reviewed 2023.
5. National Institutes of Health, National Library of Medicine. Bartonella epidemiology and clinical manifestations. J Infect Dis. 2023;227(12):1924‑1935.
6. World Health Organization. Control of Bartonellosis. 2022.

```